HemaSphere
(May 2021)
The New EU Regulation on In Vitro Diagnostic Medical Devices: Implications and Preparatory Actions for Diagnostic Laboratories
- Bart R. Lubbers,
- Anke Schilhabel,
- Christa M. Cobbaert,
- David Gonzalez,
- Isabel Dombrink,
- Monika Brüggemann,
- W. Marieke Bitter,
- Jacques J.M. van Dongen
Affiliations
- Bart R. Lubbers
- 1 Department of Immunology, Leiden University Medical Center, Leiden, The Netherlands
- Anke Schilhabel
- 2 Department of Hematology, University Hospital Schleswig-Holstein, Kiel, Germany
- Christa M. Cobbaert
- 3 Department of Clinical Chemistry and Laboratory Medicine, Leiden University Medical Center, Leiden, The Netherlands
- David Gonzalez
- 4 Centre for Cancer Research and Cell Biology, Queen’s University Belfast, Belfast, United Kingdom
- Isabel Dombrink
- 2 Department of Hematology, University Hospital Schleswig-Holstein, Kiel, Germany
- Monika Brüggemann
- 2 Department of Hematology, University Hospital Schleswig-Holstein, Kiel, Germany
- W. Marieke Bitter
- 1 Department of Immunology, Leiden University Medical Center, Leiden, The Netherlands
- Jacques J.M. van Dongen
- 1 Department of Immunology, Leiden University Medical Center, Leiden, The Netherlands
- DOI
-
https://doi.org/10.1097/HS9.0000000000000568
- Journal volume & issue
-
Vol. 5,
no. 5
p.
e568
WeChat QR code